Hennion & Walsh Asset Management, Inc. Heron Therapeutics, Inc. Transaction History

Hennion & Walsh Asset Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.66 - $5.37 $20,769 - $41,928	-7,808 Reduced 5.35%	138,200 $583,000
Q2 2022 Jul 19, 2022	SELL	$2.3 - $6.29 $317,275 - $867,680	-137,946 Reduced 48.58%	146,008 $407,000
Q1 2022 Apr 26, 2022	SELL	$4.63 - $9.94 $56,013 - $120,254	-12,098 Reduced 4.09%	283,954 $1.62 Million
Q4 2021 Feb 14, 2022	SELL	$8.35 - $12.6 $593,392 - $895,419	-71,065 Reduced 19.36%	296,052 $2.7 Million
Q3 2021 Nov 12, 2021	SELL	$10.13 - $15.0 $132,956 - $196,875	-13,125 Reduced 3.45%	367,117 $3.92 Million
Q2 2021 Aug 13, 2021	SELL	$13.27 - $18.48 $175,681 - $244,656	-13,239 Reduced 3.36%	380,242 $5.9 Million
Q1 2021 May 17, 2021	BUY	$14.49 - $20.72 $5.7 Million - $8.15 Million	393,481 New	393,481 $6.38 Million

193

129M

94.7K

148K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $227M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Hennion & Walsh Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Hennion & Walsh Asset Management, Inc. with notifications on news.